Komori
Governance2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

Report on Corporate Governance 2026/06/26

A skills matrix for the directors has been included, showing each director’s areas of expertise and qualifications. However, the text does not provide enough information to confirm any specific changes from the previous report, such as changes to the corporate governance structure or committee composition.

Worth reading
89Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Governance structure

Number of directors15 directors, including 6 independent outside directors
Number of independent officers6Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

A skills matrix and principal qualifications for each director have been included. Changes from the previous report: Not disclosed

Governance structure
ItemDetails
Number of directors15 directors, including 6 independent outside directors
Number of independent officers6
Changes this timeA skills matrix and principal qualifications for each director have been included. Changes from the previous report: Not disclosed
Items this document does not state (5)
Corporate Governance StructureCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The apparent purpose is to disclose the directors’ principal skills and qualifications, although the text does not explicitly state the reason for its inclusion.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Report on Corporate Governance 2026/06/26 | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori